Fees in Respect of Drugs and Medical Devices Regulations (SOR/2011-79)

Regulations are current to 2013-11-02 and last amended on 2013-06-07. Previous Versions

AMENDMENTS NOT IN FORCE

  • — SOR/2013-121, s. 1(3)

      • 1. (3) Section 3 of the Regulations is amended by striking out “or” at the end of paragraph (b), by adding “or” at the end of paragraph (c) and by adding the following after paragraph (c):

        • (d) a drug that is an active pharmaceutical ingredient as defined in subsection C.01A.001(1) of the Food and Drug Regulations.

  • — SOR/2013-122, s. 20

    • 20. Subsection 15(1) of the Fees in Respect of Drugs and Medical Devices RegulationsFootnote 3 is amended by adding the following in alphabetical order:

      “controlled drug”

      « drogue contrôlée »

      “controlled drug” has the same meaning as in subsection G.01.001(1) of the Food and Drug Regulations.

      “narcotic”

      « stupéfiant »

      “narcotic” has the same meaning as in section 2 of the Narcotic Control Regulations.

  • — SOR/2013-122, s. 21

    • 21. The definitions “controlled drug” and “narcotic” in section 29 of the Regulations are repealed.

  • — SOR/2013-122, s. 22

    • 22. The portion of item 7 of Schedule 1 to the Regulations in columns 1 and 2 is replaced by the following:

      Column 1Column 2
      ItemSubmission ClassDescription
      7.Switch status from prescription drug to non-prescription drugSubmissions based only on data that support the amendment, or the removal, of the reference to the medicinal ingredient on the Prescription Drug List that is applicable to the drug in question.
  • — SOR/2013-122, s. 23

    • 23. The portion of item 3 of Schedule 5 to the Regulations in column 1 is replaced by the following:

      Column 1
      ItemDescription
      3.Drugs for human use that are prescription drugs, controlled drugs or narcotics